Analysis of data from the CDC/FDA Vaccine Adverse Event Reporting System (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA

Adverse Event Reporting ◽

Guillain Barre Syndrome ◽

Event Reporting ◽

Hepatitis Vaccination ◽

The Usa ◽

PIN1 VACCINE-ASSOCIATED GUILLAIN-BARRE SYNDROME: A PHARMACOVIGILANCE ANALYSIS OF DATA IN THE UNITED STATES' VACCINE ADVERSE EVENT REPORTING SYSTEM (1990-2009)

Value in Health ◽

10.1016/j.jval.2011.02.633 ◽

2011 ◽

Vol 14 (3) ◽

pp. A113-A114

Author(s):

A.K. Ali

Keyword(s):

United States ◽

Adverse Event ◽

Reporting System ◽

The United States ◽

Adverse Event Reporting ◽

Guillain Barre Syndrome ◽

Event Reporting ◽

Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009

Vaccine ◽

10.1016/j.vaccine.2010.09.020 ◽

2011 ◽

Vol 29 (5) ◽

pp. 886-889 ◽

Cited By ~ 42

Author(s):

Nizar Souayah ◽

P.A. Michas-Martin ◽

Abu Nasar ◽

Nataliya Krivitskaya ◽

Hussam A. Yacoub ◽

...

Keyword(s):

Adverse Event ◽

Reporting System ◽

Adverse Event Reporting ◽

Guillain Barre Syndrome ◽

Event Reporting ◽

The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome

Vaccine ◽

10.1016/j.vaccine.2020.09.072 ◽

2020 ◽

Vol 38 (47) ◽

pp. 7458-7463 ◽

Cited By ~ 1

Author(s):

Elaine R. Miller ◽

Michael M. McNeil ◽

Pedro L. Moro ◽

Jonathan Duffy ◽

John R. Su

Keyword(s):

Adverse Event ◽

Reporting System ◽

Adverse Event Reporting ◽

Guillain Barre Syndrome ◽

Event Reporting ◽

Guillain-Barré Syndrome after H1N1 Vaccination in the United States: A Report Using the CDC/FDA Vaccine Adverse Event Reporting System (2009)

Neuroepidemiology ◽

10.1159/000336113 ◽

2012 ◽

Vol 38 (4) ◽

pp. 227-232 ◽

Cited By ~ 4

Author(s):

Nizar Souayah ◽

Hussam A. Yacoub ◽

Hafiz M.R. Khan ◽

P.A. Michas-Martin ◽

Daniel L. Menkes ◽

...

Keyword(s):

United States ◽

Adverse Event ◽

Reporting System ◽

The United States ◽

Adverse Event Reporting ◽

Guillain Barre Syndrome ◽

Event Reporting ◽

Comment on the contribution by Souayah et al., “Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009”

Vaccine ◽

10.1016/j.vaccine.2010.11.031 ◽

2011 ◽

Vol 29 (5) ◽

pp. 865-866 ◽

Cited By ~ 13

Author(s):

Barbara A. Slade ◽

Julianne Gee ◽

Karen R. Broder ◽

Claudia Vellozzi

Keyword(s):

Adverse Event ◽

Reporting System ◽

Adverse Event Reporting ◽

Guillain Barre Syndrome ◽

Event Reporting ◽

Guillain–Barré Syndrome After Influenza Vaccination in the United States, A Report From the CDC/FDA Vaccine Adverse Event Reporting System (1990–2009)

Journal of Clinical Neuromuscular Disease ◽

10.1097/cnd.0b013e31824db14e ◽

2012 ◽

Vol 14 (2) ◽

pp. 66-71 ◽

Cited By ~ 6

Author(s):

Nizar Souayah ◽

Hussam A. Yacoub ◽

Hafiz M.R. Khan ◽

Khosro Farhad ◽

Lubna Shafiq Mehyar ◽

...

Keyword(s):

United States ◽

Adverse Event ◽

Influenza Vaccination ◽

Reporting System ◽

The United States ◽

Adverse Event Reporting ◽

Guillain Barre Syndrome ◽

Event Reporting ◽

Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data

Drug Safety ◽

10.1007/s40264-013-0115-x ◽

2013 ◽

Vol 36 (11) ◽

pp. 1117-1123 ◽

Cited By ~ 8

Author(s):

Pankdeep Chhabra ◽

Xing Chen ◽

Sheila R. Weiss

Keyword(s):

Adverse Event ◽

Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Usa ◽

System Data ◽

Approved Drugs

Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System

Drug Safety ◽

10.1007/s40264-020-01022-2 ◽

2020 ◽

Author(s):

Henry Trumbo ◽

Karolina Kaluza ◽

Syed Numan ◽

Lawrence T. Goodnough

Keyword(s):

Adverse Event ◽

Adverse Events ◽

Drug Administration ◽

Reporting System ◽

Intravenous Iron ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Us ◽

The Usa

Comment on: Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System

Drug Safety ◽

10.1007/s40264-021-01058-y ◽

2021 ◽

Author(s):

Michael Auerbach

Keyword(s):

Adverse Event ◽

Adverse Events ◽

Drug Administration ◽

Reporting System ◽

Intravenous Iron ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Us ◽

The Usa

Signals and trends of Guillain–Barré syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems

Vaccine ◽

10.1016/j.vaccine.2020.06.038 ◽

2020 ◽

Vol 38 (34) ◽

pp. 5464-5473

Author(s):

Hankil Lee ◽

Hyun Jeong Kim ◽

Young June Choe ◽

Ju-Young Shin

Keyword(s):

Adverse Event ◽

Adverse Event Reporting ◽

Guillain Barre Syndrome ◽

Event Reporting ◽

Live Attenuated Vaccines ◽

South Korean ◽

The Us ◽

Reporting Systems ◽